Home › Funds › BROOKTREE CAPITAL MANAGEMENT › DXCM
BROOKTREE CAPITAL MANAGEMENT position in DXCM
DEXCOM INC · Health Care
BROOKTREE CAPITAL MANAGEMENT reported holding 51,898 shares of DXCM (DEXCOM INC) in its Q3 2026 13F filing — a position valued at US$4.5M, representing 3.09% of its reported portfolio and ranking #10 among its reported holdings. BROOKTREE CAPITAL MANAGEMENT has disclosed DXCM holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How BROOKTREE CAPITAL MANAGEMENT's DXCM position evolved
BROOKTREE CAPITAL MANAGEMENT first disclosed a stake in DXCM in Q3 2024 at 10,183 shares (US$683K). The position peaked in Q3 2026 at 51,898 shares, worth US$4.5M. Across 9 filings, BROOKTREE CAPITAL MANAGEMENT increased the stake 8 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 51,898 shares valued at US$4.5M — an increase of 837 shares quarter over quarter.. Notable position changes include a 34% increase in Q4 2024 (shares fell 13% over the following quarter), a 88% increase in Q2 2025 (shares fell 20% over the following quarter), a 43% increase in Q3 2025 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 10.18K | $682.67K | New |
| Q4 2024 | 13.64K | $1.06M | Add |
| Q1 2025 | 15.53K | $1.06M | Add |
| Q2 2025 | 29.25K | $2.55M | Add |
| Q3 2025 | 41.88K | $2.82M | Add |
| Q4 2025 | 44.66K | $2.96M | Add |
| Q1 2026 | 50.28K | $3.16M | Add |
| Q2 2026 | 51.06K | $3.44M | Add |
| Q3 2026 | 51.90K | $4.48M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DXCM and 13F data
DXCM (DEXCOM INC) is a Health Care company. 30 other funds we track also report a position in DXCM — the largest reported positions include Baillie Gifford & Co (US$1.25B), Castle Hook Partners LP (US$260.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DXCM
- Baillie Gifford & Co 14.52M sh · $1.25B · Q3 2026
- Castle Hook Partners LP 3.87M sh · $260.67M · Q2 2026
More on BROOKTREE CAPITAL MANAGEMENT
FAQ
How long has BROOKTREE CAPITAL MANAGEMENT held DXCM?
BROOKTREE CAPITAL MANAGEMENT has disclosed DXCM holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is BROOKTREE CAPITAL MANAGEMENT's current position in DXCM?
As of Q3 2026, BROOKTREE CAPITAL MANAGEMENT holds 51.90K shares of DXCM (DEXCOM INC), valued at $4.48M, representing 3.09% of its reported portfolio and ranking #10.
Has BROOKTREE CAPITAL MANAGEMENT been buying or selling DXCM?
In the latest 13F filing (Q3 2026), BROOKTREE CAPITAL MANAGEMENT increased its position in DXCM. The position peaked in Q3 2026 at 51.90K shares.
Which other funds hold DXCM?
Other major institutional holders of DXCM include Baillie Gifford & Co, Castle Hook Partners LP, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.